Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: A randomized, controlled clinical trial

Critical Care

Volumn 14, Issue 1, 2010, Pages

  Barbosa, Vera M ^a,b   Miles, Elizabeth A ^a   Calhau, Conceição ^c   Lafuente, Estevão ^b   Calder, Philip C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b Hospital Padre Americo   (Portugal)

^c University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FATTY ACID; FISH OIL; ICOSANOID; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; LIPID EMULSION; LIPOPOLYSACCHARIDE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; SOYBEAN OIL; AUTACOID; OMEGA 3 FATTY ACID;

ADULT; AGED; ARTICLE; BLOOD CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MALE; MORTALITY; NUTRITIONAL ASSESSMENT; PARENTERAL NUTRITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SINGLE BLIND PROCEDURE; BLOOD; EMULSION; LENGTH OF STAY; MIDDLE AGED; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; EMULSIONS; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HUMANS; INFLAMMATION MEDIATORS; LENGTH OF STAY; MALE; MIDDLE AGED; PHOSPHOLIPIDS; SEPSIS; SINGLE-BLIND METHOD; SOYBEAN OIL; TREATMENT OUTCOME;

EID: 77954907675     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8844     Document Type: Article

References (49)

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
2. Warren HS. Strategies for the treatment of sepsis. N Engl J Med 1997, 336:952-953. 10.1056/NEJM199703273361311, 9070479.
3. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554. 10.1056/NEJMoa022139, 12700374.
4. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated cost of case. Crit Care Med 2001, 29:1303-1310. 10.1097/00003246-200107000-00002, 11445675.
5. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR, Black E, Schwartz JS, Moore R, Johnson BL, Platt R, . Academic Medical Center Consortium Sepsis Project Working Group Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997, 278:234-240. 10.1001/jama.278.3.234, 9218672, Academic Medical Center Consortium Sepsis Project Working Group.
6. Osuchowski MF, Welch K, Siddiqui J, Remick DG. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 2006, 177:1967-1974.
7. Furst P, Kuhn KS. Fish oil emulsions: what benefits can they bring?. Clin Nutr 2000, 19:7-14. 10.1054/clnu.1999.0072, 10700528.
8. Grimble R. Fatty acid profile of modern lipid emulsions: scientific considerations for creating the ideal composition. Clin Nutr Suppl 2005, 1:9-15.
9. Calder PC. Use of fish oil in parenteral nutrition: rationale and reality. Proc Nutr Soc 2006, 65:264-277. 10.1079/PNS2006500, 16923311.
10. Calder PC. Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults. Proc Nutr Soc 2009, 68:252-260. 10.1017/S0029665109001268, 19426581.
11. Calder PC. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83:1505S-1519S.
12. Mascioli EA, Iwasa Y, Trimbo S, Leader L, Bistrian BR, Blackburn GL. Endotoxin challenge after menhaden oil diet: effects on survival of guinea pigs. Am J Clin Nutr 1989, 49:277-282.
13. Sadeghi S, Wallace FA, Calder PC. Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice. Immunology 1999, 96:404-410. 2326770, 10233721, 10.1046/j.1365-2567.1999.00701.x.
14. Mascioli EA, Leader L, Flores E, Trimbo S, Bistrian B, Blackburn G. Enhanced survival to endotoxin in guinea pigs fed iv fish oil emulsion. Lipids 1988, 23:623-625. 10.1007/BF02535609, 3172993.
15. Schauder P, Rohn U, Schafer G, Korff G, Schenk H-D. Impact of fish oil enriched total parenteral nutrition on DNA synthesis, cytokine release and receptor expression by lymphocytes in the postoperative period. Br J Nutr 2002, 87:S103-S110. 10.1079/BJN2001463, 11895146.
16. Weiss G, Meyer F, Matthies B, Pross M, Koenig W, Lippert H. Immunomodulation by perioperative administration of n-3 fatty acids. Br J Nutr 2002, 87:S89-S94. 10.1079/BJN2001461, 11895158.
17. Wachtler P, Konig W, Senkal M, Kemen M, Koller M. Influence of a total parenteral nutrition enriched with ω-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J Trauma 1997, 42:191-198. 10.1097/00005373-199702000-00004, 9042869.
18. Wichmann MW, Thul P, Czarnetzki HD, Morlion BJ, Kemen M, Jauch KW. Evaluation of clinical safety and beneficial effects of a fish oil containing lipid emulsion (Lipoplus, MLF541): data from a prospective, randomized, multicenter trial. Crit Care Med 2007, 35:700-706. 10.1097/01.CCM.0000257465.60287.AC, 17261965.
19. Tappy L, Berger MM, Schwarz JM, Schneiter P, Kim S, Revelly JP, Chioléro R. Metabolic effects of parenteral nutrition enriched with n-3 polyunsaturated fatty acids in critically ill patients. Clin Nutr 2006, 25:588-595. 10.1016/j.clnu.2006.03.008, 16697496.
20. Antebi H, Mansoor O, Ferrier C, Tetegan M, Morvan C, Rangaraj J, Alcindor LG. Liver function and plasma antioxcidant status in intensive care unit patients requiring total parenteral nutrition: comparison of 2 fat emulsions. JPEN J Parenter Enteral Nutr. 2004, 28:142-148. 10.1177/0148607104028003142, 15141405.
21. Mayer K, Fegbeutel C, Hattar K, Sibelius U, Krämer HJ, Heuer KU, Temmesfeld-Wollbrück B, Gokorsch S, Grimminger F, Seeger W. Omega-3 vs omega-6 lipid emulsions exert differential influence on neutrophils in septic shock: impact on plasma fatty acids and lipid mediator generation. Intensive Care Med 2003, 29:1472-1481. 10.1007/s00134-003-1900-2, 12897994.
22. Mayer K, Gokorsch S, Fegbeutel C, Hattar K, Rosseau S, Walmrath D, Seeger W, Grimminger F. Parenteral nutrition with fish oil modulates cytokines response in patients with sepsis. Am J Resp Crit Care Med 2003, 167:1321-1328. 10.1164/rccm.200207-674OC, 12615625.
23. Heller AR, Rossler S, Litz RJ, Stehr SN, Heller SC, Koch R, Koch T. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 2006, 34:972-979. 10.1097/01.CCM.0000206309.83570.45, 16484909.
24. Friesecke S, Lotze C, Köhler J, Heinrich A, Felix SB, Abel P. Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial. Intensive Care Med 2008, 34:1411-1420. 10.1007/s00134-008-1072-1, 18357434.
25. Wang X, Li W, Li N, Li J. Omega Fatty Acids-Supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study. JPEN J Parent Ent Nutr 2008, 32:236-241. 10.1177/0148607108316189.
26. Gadek JE, DeMichele SJ, Karlstad MD. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999, 27:1409-1420. 10.1097/00003246-199908000-00001, 10470743.
27. Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006, 34:1033-1038. 10.1097/01.CCM.0000206111.23629.0A, 16484911.
28. Pontes-Arruda A, Aragão AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006, 34:325-2333.
29. Simoens CM, Deckelbaum RJ, Massaut JJ, Carpentier YA. Inclusion of 10% fish oil in mixed medium-chain triacylglycerol-long-chain triacylglycerol emulsions increases plasma triacylglycerol clearance and induces rapid eicosapentaenoic acid (20:5n-3) incorporation into blood cell phospholipids. Am J Clin Nutr 2008, 88:282-288.
30. Harris JA, Benedict FG. Biometric Study of Basal Metabolism in Man. 1919, Washington DC: Carnegie Institute.
31. Yaqoob P, Pala HS, Cortina-Borja M, Newsholme EA, Calder PC. Encapsulated fish oil enriched in α-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur J Clin Invest 2000, 30:260-274. 10.1046/j.1365-2362.2000.00623.x, 10692004.
32. Burdge GC, Wright P, Jones AE, Wootton SA. A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Br J Nutr 2000, 84:781-787.
33. Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 2000, 35:1305-1312. 10.1007/s11745-000-0646-3, 11201991.
34. Köller M, Senkal M, Kemen M, König W, Zumtobel V, Muhr G. Impact of omega-3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery. Clin Nutr 2003, 22:59-64. 10.1054/clnu.2002.0592, 12553951.
35. Senkal M, Haaker R, Linseisen J, Wolfram G, Homann HH, Stehle P. Preoperative oral supplementation with long-chain Omega-3 fatty acids beneficially alters phospholipid fatty acid patterns in liver, gut mucosa, and tumor tissue. JPEN J Parent Ent Nutr 2005, 29:236-240. 10.1177/0148607105029004236.
36. Morlion BJ, Torwesten E, Lessire H, Sturm G, Peskar BM, Fürst P, Puchstein C. The effect of parenteral fish oil on leukocyte membrane fatty acid composition and leukotriene-synthesizing capacity in patients with postoperative trauma. Metabolism 1996, 45:1208-1213. 10.1016/S0026-0495(96)90237-1, 8843174.
37. Tsekos E, Reuter C, Stehle P, Boeden G. Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery. Clin Nutr 2004, 23:325-330. 10.1016/j.clnu.2003.07.008, 15158295.
38. Meyer K, Kiessling A, Ott J, Schaefer MB, Hecker M, Henneke I, Schilz R, Gunther A, Wang J, Wu L, Roth J, Seeger W, Kang JX. Acute lung injury is reduced in fat-1 mice endogenously synthesizing n-3 fatty acids. Am J Resp Crit Care Med 2009, 179:474-483. 10.1164/rccm.200807-1064OC, 19136374, 2654977.
39. Kirchhoff C, Biberthaler P, Mutschler WE, Faist E, Jochum M, Zedler S. Early down-regulation of the pro-inflammatory potential of monocytes is correlated to organ dysfunction in patients after severe multiple injury: a prospective cohort study. Crit Care 2009, 13:R88. 2717459, 19519886, 10.1186/cc7914.
40. Heidecke C-D, Weighardt H, Hensler T, Bartels H, Holzmann B. Immunparalyse von T-lymphocyten und monocyten in der postoperativen abdominellen sepsis. Chirurg 2000, 71:159-165. 10.1007/s001040050028, 10734584.
41. Arnalich F, Garcia-Palomero E, Lopez J, Jimenez M, Madero R, Renart J, Vazquez JJ, Montiel C. Predictive value of nuclear factor κB activity and plasma cytokine levels in patients with sepsis. Infect Immun 2000, 68:1942-1945. 97370, 10722586, 10.1128/IAI.68.4.1942-1945.2000.
42. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007, 11:R49. 2206478, 17448250, 10.1186/cc5783.
43. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993, 103:565-575. 10.1378/chest.103.2.565, 8432155.
44. LaRue KE, McCall CE. A labile transcriptional repressor modulates endotoxin tolerance. J Exp Med 1994, 180:2269-2275. 2191765, 7964499, 10.1084/jem.180.6.2269.
45. Bohuslav J, Kravchenko VV, Parry GC, Erlich JH, Gerondakis S, Mackman N, Ulevitch RJ. Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J Clin Invest 1998, 102:1645-1652. 509112, 9802878, 10.1172/JCI3877.
46. Kohler NG, Joly A. The involvement of an LPS inducible I kappa B kinase in endotoxin tolerance. Biochem Biophys Res Commun 1997, 232:602-607. 10.1006/bbrc.1997.6337, 9126320.
47. Calder PC. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 2009, 91:791-795. 10.1016/j.biochi.2009.01.008, 19455748.
48. Singer P, Shapiro H, Theilla M, Anbar R, Singer J, Cohen J. Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrated perspective. Intens Care Med 2008, 34:1580-159. 10.1007/s00134-008-1142-4.
49. Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 2007, 28:176-183. 10.1016/j.it.2007.02.007, 17337246.